The Global Gelling Fibers Market is anticipated to gain traction from rising risk of injuries and wounds, especially in the aged population. Fortune Business Insights recently published a report, titled “Gelling Fibers Market Size, Share and Global Trend by Product Type (Gelling Fibre with Silver Ions, Gelling Fibers without Silver Ions), By Material Type (Carboxymethyl Cellulose (CMC), Polyvinyl Alcohol), By End-User (Hospitals & Trauma Centers, Speciality Clinics, Ambulatory Surgery Centers) and Geography Forecast till 2026” offers some of the valuable insights on factors driving growth of the market.
As per a study conducted by the National Centre for Injury Prevention and Control (NCIPC), around 23.1% of people aged less than 75 years succumbed to death in the year 2015. These people died suffering from injuries or wounds. This is further expected to increase the use of gelling cellulose fibers for dressing wounds.
Demand for Gelling Fibers to rising Majorly from Hospitals
“Hospitals are likely to witness rising demand for gelling fiber dressings among other end users,” stated a lead analyst at Fortune Business Insights. “This is majorly ascribable to the increasing number of surgeries conducted every day across several multispecialty hospitals,” he added.
Among materials, carboxymethyl cellulose or CMC is estimated to cover a major share in the global gelling fibers market. The rising use of CMC for developing gelling fibers is driving the growth of this segment. Fortune Business Insights predicts the demand for CMC to remain high in the upcoming years.
Request Sample Copy at https://www.fortunebusinessinsights.com/enquiry/sample/gelling-fibers-market-100241
Government Support to Promote Growth in North America
From a geographical standpoint, North America is expected to account for the majority of the share in the global gelling Fibers market throughout the forecast period. The governments in the region are introducing favorable guidelines regarding post-operative care. In addition to this, awareness initiatives are conducted by governments about the use of gelling Fibers, especially for wound dressings.
These factors are projected to register lucrative growth opportunities for the global market in the forecast years. Trailing North America, Europe is also estimated to grow considerably across several countries during the forecast period. An increasing number of strategic collaborations with key companies to enhance healthcare infrastructure is expected to drive the market in this region. Other regions such as Asia Pacific and the Middle East & Africa are also estimated to grow at a steady rate over the forecast years.
Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/gelling-fibers-market-100241
Technological Advancements in Gelling Fibers to Bode Well for the Market
The global gelling Fibers market is expected to grow from a rising prevalence of lacerations, which results in irregular wounds. Furthermore, the introduction of advanced gelling Fibers such as biosorb gelling Fibers is boosting the market’s growth. Gelling Fibers for heat protection and flame are developed to help cure patient’s suffering from burn injuries. Besides this, the market is expected to gain from the rising incidence of post-operative surgical injuries and other different types of wounds. The demand for different types of gelling Fibers such as gelling cellulose Fibers and gelling dietary Fibers is likely to increase during the forecast years. Also, wounds regarding diabetic ulcers, cavity, trauma wounds, pressure ulcers, and skin grafting are expected to stimulate growth in the market by 2026. Also, gelling Fibers have replaced traditional alginate Fibers which in turn, is expected to register remarkable growth for the global gelling Fibers market.
Business Strategies Adopted by Companies to Expand Their Product Portfolio
Several leading players are focussing on the adoption of new strategies in order to increase their market share. Some of the leading players operating in the global market include Mölnlycke Health Care AB, Crawford Healthcare Limited, Smith & Nephew, DermaRite Industries, LLC., Safe n’ Simple, Cardinal Health, ConvaTec Inc., and Gentell Corp.
Some of the strategies adopted by companies are mentioned below:
- FDA granted the marketing approval on a gelling fiber producer called SURECELL. This product was developed in May 2018 by Jiangsu Newvalue Medical Products Co., Ltd. for the treatment of wounds or injuries.
- Mölnlycke Health Care AB launched a new wound dressing product called Mepilex Border Flex in November 2018. The product was launched at the Symposium on Advanced Wound Care Fall.
- Acelity launched a gelling fiber called BIOSORB in July 2016. This product was developed with for advanced wound management in the U.S. and received a Conformité Européenne (CE) Mark in Europe.
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245